| Primary |
| Postoperative Care |
38.2% |
| Preoperative Care |
14.5% |
| Antibiotic Prophylaxis |
7.3% |
| Glaucoma |
7.3% |
| Uveitis |
5.5% |
| Cataract Operation |
3.6% |
| Eye Disorder |
3.6% |
| Ocular Hyperaemia |
3.6% |
| Seborrhoeic Dermatitis |
3.6% |
| Conjunctivitis |
1.8% |
| Corneal Transplant |
1.8% |
| Eye Inflammation |
1.8% |
| Eye Laser Surgery |
1.8% |
| Hyphaema |
1.8% |
| Intraocular Pressure Increased |
1.8% |
| Multiple Myeloma |
1.8% |
|
| Vision Blurred |
15.8% |
| Visual Acuity Reduced |
15.8% |
| Ulcerative Keratitis |
10.5% |
| Blindness |
5.3% |
| Cushing's Syndrome |
5.3% |
| Eye Irritation |
5.3% |
| Hallucination |
5.3% |
| Visual Impairment |
5.3% |
| Adrenal Insufficiency |
2.6% |
| Atrial Fibrillation |
2.6% |
| Confusional State |
2.6% |
| Corneal Decompensation |
2.6% |
| Corneal Defect |
2.6% |
| Diabetes Mellitus |
2.6% |
| Disease Recurrence |
2.6% |
| Endophthalmitis |
2.6% |
| Eye Disorder |
2.6% |
| Eyelid Infection |
2.6% |
| Facial Paresis |
2.6% |
| Fatigue |
2.6% |
|
| Secondary |
| Drug Use For Unknown Indication |
38.8% |
| Acute Lymphocytic Leukaemia |
14.1% |
| Postoperative Care |
7.1% |
| Uveitis |
7.1% |
| Blood Pressure |
3.5% |
| Glaucoma |
3.5% |
| Prophylaxis |
3.5% |
| Ulcerative Keratitis |
3.5% |
| Aspergillosis |
2.4% |
| Choroidal Neovascularisation |
2.4% |
| Conjunctivitis |
2.4% |
| Intraocular Lens Implant |
2.4% |
| Keratoconjunctivitis Sicca |
2.4% |
| Macular Degeneration |
2.4% |
| Type 2 Diabetes Mellitus |
2.4% |
| Acute Leukaemia |
1.2% |
| Eye Disorder |
1.2% |
|
| Vomiting |
15.6% |
| Mydriasis |
12.5% |
| Erythema Multiforme |
6.3% |
| Pancytopenia |
6.3% |
| Uveitis |
6.3% |
| Vision Blurred |
6.3% |
| Visual Acuity Reduced |
6.3% |
| Antinuclear Antibody Positive |
3.1% |
| Blood Thyroid Stimulating Hormone Increased |
3.1% |
| Corneal Deposits |
3.1% |
| Corneal Thinning |
3.1% |
| Dizziness |
3.1% |
| Eye Inflammation |
3.1% |
| Eyelid Pain |
3.1% |
| Feeling Hot |
3.1% |
| Intraocular Pressure Increased |
3.1% |
| Mental Impairment |
3.1% |
| Neuropathy Peripheral |
3.1% |
| Post Procedural Complication |
3.1% |
| Sensation Of Foreign Body |
3.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
19.6% |
| Product Used For Unknown Indication |
13.4% |
| Breast Cancer |
7.3% |
| Hormone Replacement Therapy |
7.3% |
| Hypertension |
6.1% |
| Pain |
5.4% |
| Rheumatoid Arthritis |
5.2% |
| Neck Pain |
4.7% |
| Hiv Infection |
3.8% |
| Glaucoma |
3.3% |
| Multiple Myeloma |
3.1% |
| Prophylaxis |
3.1% |
| Atrial Fibrillation |
2.4% |
| Eye Inflammation |
2.4% |
| Uveitis |
2.4% |
| Acute Lymphocytic Leukaemia |
2.1% |
| Back Pain |
2.1% |
| Non-small Cell Lung Cancer |
2.1% |
| Orchitis |
2.1% |
| Osteoporosis |
2.1% |
|
| Pulmonary Embolism |
8.1% |
| Uveitis |
8.1% |
| Pneumonia |
6.8% |
| Pneumonitis |
6.8% |
| Glomerulosclerosis |
5.4% |
| Oedema Peripheral |
5.4% |
| Tremor |
5.4% |
| Vomiting |
5.4% |
| Breast Cancer |
4.1% |
| Breast Cancer Female |
4.1% |
| Death |
4.1% |
| Fat Necrosis |
4.1% |
| Renal Failure |
4.1% |
| Respiratory Failure |
4.1% |
| Syncope |
4.1% |
| Thrombocytopenia |
4.1% |
| Urinary Tract Infection |
4.1% |
| Urticaria |
4.1% |
| Vision Blurred |
4.1% |
| Visual Field Defect |
4.1% |
|
